DEDICATED SUPPORT FOR YOUR TREATMENT EXPERIENCE
LIVE

Serial Number

97740705

Owner

Cytokinetics, Incorporated

Attorney

B. Brett Heavner

Filing Date

Jan 4, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DEDICATED SUPPORT FOR YOUR TREATMENT EXPERIENCE Trademark

Serial Number: 97740705

DEDICATED SUPPORT FOR YOUR TREATMENT EXPERIENCE is a trademark filed by Cytokinetics, Incorporated on January 4, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Cytokinetics, Incorporated (28 trademarks)

350 Oyster Point Blvd
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

January 4, 2023

Registration Date

Not Registered

Published for Opposition

April 2, 2024

Goods & Services

Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers

providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers

Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions

Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs

Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 2, 2026 EXRA
SOU EXTENSION 4 GRANTED
Jun 1, 2026 EX4G
SOU EXTENSION 4 FILED
Jun 1, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 1, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 2, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 15, 2025 EX2G
SOU EXTENSION 2 FILED
May 14, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
May 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 9, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 9, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 27, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 18, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 20, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 12, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 27, 2023 NWOS
NEW APPLICATION ENTERED
Jan 7, 2023 NWAP